Delivery Order SPE2DB25D3018-SPE2DB25FUXAJ

Award Date 3/17/25
Potential Completion Date 3/18/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of SPE2DB20D1100|SPE2DB25FY56G, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a ceiling value of $11,458.56 and a performance period ending on October 17, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. AmerisourceBergen Drug Corp is a major...
This federal contract award, with ID SPE2DB22D3301|SPE2DB24FX8EF, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $45,082.30, is a Firm Fixed Price Delivery Order for the supply of HUMIRA PEN 40 MG/0.8 MLS, a pharmaceutical product. The contract has an ultimate completion date of January 8, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies medical...
This federal contract award, with ID SPE2DB20D1051|SPE2DB24FD6FV, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a ceiling value of $7,130.90 and a completion date of December 12, 2023. This is a firm fixed price delivery order contract. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award, valued at $4,741.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of February 25, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award, with an ID of SPE2DB20D1109|SPE2DB25FN42G, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a ceiling value of $2,265.90 and a completion date of January 21, 2025. This is a Firm Fixed Price Delivery Order contract, and no set-aside was utilized. AmerisourceBergen Drug...
This federal contract award, identified as SPE2DB20D3103|SPE2DB25FM3D8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a ceiling value of $8,969.40 and a completion date of January 15, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen Drug...
This federal contract award, valued at $2,643.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, and has a completion date of February 27, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FPT41, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Humira (CF) Pen 80 mg/0.8 mL, a pharmaceutical product. The contract has a ceiling value of $2,791.68 and a period of performance through March 4, 2025. It is a firm-fixed-price delivery order contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award, with ID SPE2DB22D2006|SPE2DB25FV8VV, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a firm fixed price ceiling value of $1,083.47 and a completion date of March 5, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This federal contract award, valued at $3,703.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of February 28, 2025 and is a Firm Fixed Price Delivery Order. The award is not associated with a set-aside...
  • SPE2DB25D3018
    Indefinite Delivery Contract
  • SPE2DB25D3018-SPE2DB25FUXAJ
    Delivery Order

This federal contract award, with the ID SPE2DB25D3018|SPE2DB25FUXAJ, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a ceiling value of $2,265.90 and a final completion date of March 18, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/16/25, 10:55 AM